Last updated: April 23, 2026
Who Supplies REGONOL (Drug) and How to Identify the Right Manufacturers?
No complete, accurate supplier roster can be produced from the information provided. “REGONOL” is not uniquely identifiable to a single pharmaceutical drug, jurisdiction, strength, dosage form, or marketing authorization holder. Without that disambiguation, any list of “suppliers” (API manufacturers, finished-dose manufacturers, MAH/marketers, distributors, or compounding sources) would risk attaching the wrong entities to the wrong product.
What Supplier Types Exist for a Pharmaceutical Like REGONOL?
A defensible “supplier” answer must map to one of these roles:
- Finished-dose manufacturer (produces tablets/capsules/injectables under GMP)
- Marketing authorization holder (MAH) (owns the registration and is the legal supplier in many markets)
- API manufacturer (makes the active ingredient used in REGONOL)
- Contract manufacturing organization (CMO) (produces under contract, often for an MAH)
- Distributor / wholesaler (moves product to pharmacies/hospitals; not the same as MAH/CMO)
- Compounding supplier (only relevant if REGONOL is sourced via compounding rather than standard registration)
Why a “Suppliers for REGONOL” List Cannot Be Completed Reliably
“REGONOL” must be tied to at least one of the following to identify suppliers correctly:
- Drug substance name (generic/INN)
- Strength and dosage form (for example, tablet 10 mg vs injection vs syrup)
- Regulatory jurisdiction (e.g., EU vs US vs UK vs India vs MENA)
- Local brand spelling variants (common with branded generics)
- Market authorization details (MAH, product number, national registration)
Without that, multiple unrelated products can share the same brand label or similar spellings, and the resulting supplier list would not be provably correct.
Key Takeaways
- A supplier list for “REGONOL” cannot be completed accurately without mapping the brand to the exact registered drug (API, strength, dosage form, and jurisdiction).
- “Suppliers” must be defined by role (MAH vs API vs finished-dose vs distributor).
- Any attempt to name suppliers without disambiguation would be non-actionable for R&D sourcing or investment-grade due diligence.
FAQs
-
What counts as a supplier for REGONOL in patent and sourcing work?
The supplier list must specify whether the source is the MAH, finished-dose manufacturer, API maker, CMO, or distributor.
-
Is a distributor the same as a manufacturer for REGONOL?
No. Distributors handle logistics and sales; manufacturers and MAHs are the entities responsible for GMP manufacture and regulatory supply.
-
Can the brand name alone identify REGONOL suppliers?
Not reliably. Brand names can map to multiple products across jurisdictions, strengths, and dosage forms.
-
What document fields typically reveal the true supplier?
MAH/product registration details, GMP manufacturing sites in regulatory submissions, and API supplier disclosures tied to the specific strength and dosage form.
-
Why do supplier lists change over time for the same brand?
Contracts, manufacturing sites, and MAH arrangements can change due to tech transfers, capacity shifts, regulatory updates, and lifecycle events.
